Abstract:Objective: To investigate the expression and significationof p53 and p16 in cervical intraepithelial neoplasia and cervical carcinoma.Methods: Expression of p53 and p16 were detected by immunohistochemistry method in 79 cases of cervical intraepithelial neoplasia(CIN),79 csae of cervical squamous cell carcinoma and 16 normal cervical specimens.Results: In normal cervical specimens,CIN and cervical squamous cell carcinoma the positive rates of p53 were 0.00%,47.77% and 60.76%,respectively with significant difference(P<0.01);In CINⅠ,Ⅱ,Ⅲ the positive rates of p16 were 0.00%,37.97% and 67.09%,respectively also with significant difference(P<0.01).The positive rates of p53 were 24.14%,42.31% and 62.50%,respectively with significant difference(P<0.05);the positive rates of p16 were 13.79%,38.46%,and 66.67%,respectively with significant difference(P<0.01).The positive rates of p53 and p16 in the those in CIN with condyloma were higher than CIN without condyloma,but without statistic difference(P>0.05).With cervical squamous cell carcinoma's tumor grades increased the expression of p16(P<0.05),while the expression of p53 decreased.Conclusion: The expression of p53 increase with CIN grades increase,and shows overexpression in cervical squamous cell carcinoma,the gene mutant of p53 is associated with the pathogenesis and developoment of cervical squamous cell carcinoma,especially in the early stage of pathogenesis.With cervical squamous cell carcinima's tumor grades and CIN grades increased,the expression of p16 increases significantly p16 may be an importance in CIN grades and the diagnosis of cervical squamous cell carcinoma.

The Expression of p16 and p53 Tumor Suppressor Gene in Bladder Carcinoma

The relationship of expression of p53,p21,Ki-67 and VEGF and bladder cancer stage,grade and prognosis

Relationship between the expression of mutant P53 and PCNA and their clinical significances in transitional cell carcinoma of the bladder

Expressions of P16 Protein and PCNA in Transitional Cell Carcinoma of the Urinary Bladder and Their Implications

EXPRESSION OF P53 PRODUCT IN CHINESE HUMAN BLADDER-CARCINOMA

Expressions of P53, Nm23, Bcl-2 in Bladder Transitional Cell Carcinoma and Its Clinical Significance

The Relationship Between the Expression of Mutant p53 and VEGF and the Clinical Significances in Transitional Cell Carcinoma of the Bladder

Clinical Value of P_53 Gene Mutation in Bladder Cancer

Significance of Study on P16 Gene Loss in Primary Transitional Cell Carcinomas of Urinary Bladder

Expression of P16 Protein and Cyclind1 Protein in Transitional Cell Carcinoma(tcc) of Urinary Bladder and Their Implications

Expressions and clinical significances of PTEN and P53 gene in non-muscle-invasive bladder cancer

The expression of 53 in cervical carcinoma

Microarray study on the expression of p53,VEGF,E-cad and CK20 in bladder tumor

Expression of Bmi-1 and p16 gene in transitional cell carcinoma of bladder

MTS1 Product P16 Expression in Bladder Transitional Cell Carcinoma

Study of p16 gene loss and mutation in primary transitional cell carcinomas of urinary bladder

Expressions Correlation of P53,vegf,cox-2 and EGFR in Bladder Cancer and Their Clinical Significance

The Frequency Of P53 Mutation In The Bladder Transitional Cell Carcinoma

Expression and Signification of p53 and p16 in Cervical Intraepithelial Neoplasia and Cervical Carcinoma.

The Expression of P16 and P53 Protein and Their Significance in Breast Carcinoma

Companied P16 genetic and protein status together providing useful information on the clinical outcome of urinary bladder cancer